Shares of Cartesian Therapeutics rose after the company reported 2025 revenue ahead of Wall Street expectations despite widening its loss for the year. Shares were up 29% to $8.81 in Monday afternoon ...

Abstract: Analytical expressions that have been derived to calculate ac resistance and losses of magnetic devices at high frequencies have primarily used a one-dimensional approximation, and have used ...

In his column “Acrademics,” Alexandre Acra ’26 sheds light on the ins and outs of Stanford and Silicon Valley culture. Dear Acrademics, The world around us seems to be losing rigor and specificity by ...

Investors might want to bet on Cartesian Therapeutics, Inc. (RNAC), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

I am trying to build an installer for Linux but scripts/release-common.sh fails/stops. First it does not build an AppImage. Instead it builds an openscad-*.x86-64.tar.gz but that stops on the strip ...

Background: In my experience, given a customizer initialization the spinner usually increments the last digit. Eg, if testparam8=0.567; appears, the increment is 0.001. Problem: While the increment is ...

Cartesian Therapeutics, Inc. has announced the enrollment of the first participant in its Phase 3 AURORA trial for Descartes-08, its lead cell therapy candidate aimed at treating myasthenia gravis (MG ...

NEW YORK--(BUSINESS WIRE)--Cartesian Growth Corporation III (the “Company”) announced today the closing of its initial public offering of 27,600,000 units, including 3,600,000 units pursuant to the ...

NEW YORK--(BUSINESS WIRE)--Cartesian Growth Corporation III (the “Company”) announced today the pricing of its initial public offering of 24,000,000 units, upsized from 20,000,000 units, at a price of ...